Back to top of page

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

List of Required Information for Application:

1. Name of the Applicant/Principal Investigator

2. Contact Information (Email, Phone number, and Address)

3. Affiliation/Organization details of the Applicant/Principal Investigator

4. Project Title

5. Project Summary/Abstract

6. Project Description/Research Plan

7. Significance and Relevance of the Project to Alzheimer's Disease

8. Objective(s) of the Project

9. Proposed Approach/Methodology

10. Expected outcomes and impact of the project

11. Budget and Justification for the requested funding support

12. Timeline/Timetable for the project implementation

13. Qualifications and expertise of the Applicant/Principal Investigator and their research team

14. Institutional Support/Commitment

15. Relevant past research accomplishments/acknowledgments

16. Ethical considerations and compliance with regulatory guidelines

17. Data Management and Sharing Plan (if applicable)

18. References/Citations to support the proposed project

19. Additional Documentation (CVs of Investigators, Letters of collaboration/support, etc.)

20. Any other relevant information related to the proposed project.

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows